A Study of Valemetostat Tosylate in Combination With DXd ADCs in Subjects With Solid Tumors
Conditions
Advanced Solid Tumor
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
City of Hope At Orange County Lennar Foundation Cancer Center, Irvine, California, United States
Valkyrie Clinical Trials, Los Angeles, California, United States
Sharp Memorial Hospital, San Diego, California, United States
Brcr Medical Center, Inc Dba Boca Raton Clinical Research, Plantation, Florida, United States
H. Lee Moffitt Cancer Center and Research Institute, Inc, Tampa, Florida, United States
University of Hawaii At Manoa, Honolulu, Hawaii, United States
University of Chicago Medical Center, Chicago, Illinois, United States
Dana-Farber Cancer Institute, Boston, Massachusetts, United States
Memorial Sloan-Kettering Cancer Center (Mskcc) - New York, New York, New York, United States
Clinical Research Alliance, Westbury, New York, United States
Unc Hospitals, Chapel Hill, North Carolina, United States
The Cleveland Clinic Foundation, Cleveland, Ohio, United States
Providence Portland Medical Center, Portland, Oregon, United States
Mary Crowley Cancer Research Centers, Dallas, Texas, United States
Ut Southwestern Medical Center, Dallas, Texas, United States
University of Texas M. D. Anderson Cancer Center, Houston, Texas, United States
Inova Schar Cancer Institute, Fairfax, Virginia, United States
Next Virginia, Fairfax, Virginia, United States
Fred Hutchinson Cancer Center, Seattle, Washington, United States
Medical College of Wisconsin, Milwaukee, Wisconsin, United States
Peking University Third Hospital, Beijing, China
Sun Yat-Sen University, Cancer Center, Guangzhou, China
SunYat-Sen University Cancer Center, Guangzhou, China
Harbin Medical Univeristy Cancer Hospital, Heilongjiang, China
Hunan Cancer Hospital, Hunan, China
Jilin Cancer Hospital, Jilin, China
Jinana Center Hosptial, Shandong, China
IRCCS Istituto Scientifico Romagnolo Per, Cesena, Italy
National Cancer Center Hospital, Chūōku, Japan
National Hospital Org-Kyushu Cancer Center, Fukuoka, Japan
National Cancer Center Hospital East, Kashiwa, Japan
The Cancer Institute Hospital of Jfcr, Kōtoku, Japan
Aichi Cancer Center Hospital, Nagoya, Japan
Osaka International Cancer Institute, Osaka, Japan
Kindai University Hospital, Ōsaka-sayama, Japan
Shizuoka Cancer Center, Shizuoka, Japan
Osaka University Hospital, Suita, Japan
Kanagawa Cancer Center, Yokohama, Japan
Study leads
Global Clinical Leader
Study Director
Daiichi Sankyo